It has been previously reported that loss of DPP4 immunostaining helps to discriminate malignant melanomas from deep penetrating nevi, a variant of benign melanocytic nevus [130] and early reports of their absence in metastatic melanomas exist [131], [132]. The gene discussed is DPP4; the disease is benign melanocytic skin nevus.